Abstract
Background/Aim: Angiomyomas are rare benign smooth muscle tumors originating from the tunica media of blood vessel walls, most frequently affecting the lower extremities in middle-aged women.
Case Report: We report the case of a 51-year-old female with a six-month history of a painful, palpable mass in the right heel. Physical examination revealed a soft, mobile, and tender subcutaneous nodule. Ultrasound imaging identified a 0.5 cm well-defined hypoechoic lesion in the subcutaneous layer, without internal blood flow, initially suspected to be an epidermoid cyst or fibrous tumor. Surgical excision of the lesion was performed, and histopathological analysis revealed a well-encapsulated tumor consisting of spindle-shaped cells with eosinophilic cytoplasm and bland nuclei, accompanied by vascular components. Immunohistochemical staining confirmed positive expression of SMA, establishing the diagnosis of angiomyoma. The patient experienced an uneventful postoperative recovery.
Conclusion: This case highlights the diagnostic challenges of angiomyomas, given their nonspecific clinical presentation and imaging findings. While magnetic resonance imaging may reveal characteristic features such as strong gadolinium enhancement, definitive diagnosis relies on histopathological evaluation. Clinicians should include angiomyoma in the differential diagnosis of painful subcutaneous masses in the foot and ankle, particularly in middle-aged women. Surgical excision remains the definitive diagnostic and therapeutic approach, with low recurrence rates reported.
Introduction
Soft tissue tumors of the foot and ankle are relatively uncommon, with the majority being benign. Among these, giant cell tumors are the most frequently encountered benign lesions (1, 2). Other benign tumors, including angiomyoma, lipoma and schwannoma, may also occur but are less common. Accurate clinical or radiological diagnosis of these tumors can be challenging due to their rarity and the limited literature available. In this report, we describe a case of a painful angiomyoma in the heel region. This study was approved by the Institutional Review Board (IRB) of Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, and adhered to ethical guidelines (IRB No. C202415173, approved on October 8, 2024). Written informed consent was obtained from the patient for publication of this report.
Case Report
A 51-year-old female presented to our clinic with a palpable mass over the right heel, which had been persisted for six months. She denied any history of trauma or prior surgeries. Physical examination revealed a soft, mobile mass in the right heel region (Figure 1A and B), with tenderness on palpation. Ultrasound examination identified a 0.5 cm well-defined hypoechoic nodule located in the subcutaneous layer beneath the dermis. The lesion showed no internal blood flow and was suspected to be an epidermoid cyst or fibrous tumor (Figure 2). The mass was excised, and gross examination revealed a soft, gray specimen (Figure 1C). Histopathological analysis demonstrated a well-encapsulated tumor with an eosinophilic smooth muscle component (Figure 3A). At higher magnification, spindle-shaped tumor cells displayed eosinophilic cytoplasm and bland nuclei without atypia, along with aggregated vascular components (Figure 3B). Immunohistochemical staining showed positive expression of SMA in the tumor cells (Figure 3C), confirming myogenic and smooth muscle differentiation consistent with angiomyoma. The patient experienced an uneventful recovery postoperatively.
Clinical and gross appearance of the lesion. (A, B) A soft, movable subcutaneous tumor located in the right heel region. (C) The excised specimen appears gray in color and has a soft consistency, measuring approximately 0.5 cm in size.
Ultrasonographic findings. (A, B) A 0.5 cm well-defined hypoechoic nodule observed in the subcutaneous layer beneath the dermis of the right heel region. No internal blood flow is detected.
Histopathological and immunohistochemical analysis. (A) A well-encapsulated tumor composed of eosinophilic smooth muscle is identified (H&E stain, 40×). (B) Higher magnification reveals spindle-shaped tumor cells with eosinophilic cytoplasm, bland nuclei lacking atypia, and aggregated vascular components (H&E stain, 200×). (C) Immunohistochemical staining for SMA demonstrates positivity in the tumor cells, confirming smooth muscle differentiation (IHC stain, SMA, 200×).
Discussion
Most subcutaneous tumors in the foot and ankle are benign. The differential diagnosis includes giant cell tumor, angiomyoma, lipoma, epidermoid cyst and schwannoma, although angiomyomas are less commonly encountered. Angiomyomas, a subtype of leiomyomas (3), are benign smooth muscle tumors originating from the tunica media of blood vessel walls (4, 5). The peak incidence occurs between the fourth and sixth decade of life, with a predilection for the lower extremities, particularly in women (6), which is consistent with our case. Clinically, patients often present with pain, especially in weight-bearing areas such as the heel (3). The pain is thought arise from nerve compression or ischemia within the tumor. In our case, the patient’s only symptom was pain, without evidence of neurovascular involvement.
Due advancements in imaging modalities such as ultrasound and magnetic resonance imaging (MRI), diagnosing angiomyomas remains challenging due to their nonspecific clinical presentation. On MRI, angiomyomas typically appear as well-defined lesions surrounded by a thin hypointense capsule. They are homogeneous and isointense to skeletal muscle on T1-weighted sequences, while on T2-weighted and short tau inversion recovery sequences, they display heterogeneously increased signal intensity compared to skeletal muscle. Additionally, angiomyomas generally show strong enhancement following gadolinium contrast administration (7). However, these MRI characteristics are still relatively nonspecific, underscoring the need for histopathological confirmation.
In the presented case, only an ultrasound examination was performed. Ogata et al. suggested that a combination of thorough physical examination and ultrasonographic evaluation is typically sufficient to differentiate angiomyomas from schwannomas (8). Angiomyomas are generally smaller (<0.2 cm) and lack the entering or exiting nerve roots commonly observed in schwannomas. Key features such as tumor size, location, and the presence or absence of associated nerve roots can aid in distinguishing between these two entities. Szolomayer et al. reported eight cases of leiomyomas in the foot and ankle, with an average size of 3.85 cm-significantly larger than the 0.5 cm lesion observed in our case (7). The smaller size in our case increased the likelihood of misdiagnosis as another type of subcutaneous tumor. Surgical excision, combined with immunohistochemical staining, remains the gold standard for diagnosing these tumors. Positive immunohistochemical staining for SMA confirms the diagnosis of angiomyoma. Notably, a low recurrence rate has been reported following excision (9).
In conclusion, we present a case of angiomyoma in the heel region, highlighting its clinical presentation alongside radiographic and histological features. A combination of meticulous physical examination and ultrasonographic evaluation can aid in establishing the diagnosis. Clinicians should consider angiomyoma as a differential diagnosis for painful subcutaneous tumors in the foot and ankle, particularly in middle-aged female patients.
Acknowledgements
This study was partially funded by grants from the Tri-Service General Hospital in Taiwan (TSGH_D_113119 and TSGH_E_114263).
Footnotes
Authors’ Contributions
Conceptualization: Y.-Y.T., J.-W.L., H. Y. and C.-C.W.; investigation: Y.-Y.T., J.-W.L., H. Y. and C.-C.W.; writing-original draft preparation: Y.-Y.T., J.-W.L. and C.-C.W.; writing-review and editing: Y.-Y.T., J.-W.L. and C.-C.W.; visualization: H. Y. and C.-C.W.; supervision: C.-C.W. All Authors have read and agreed to the published version of the manuscript.
Conflicts of Interest
The Authors declare no conflicts of interest in relation to this study.
Artificial Intelligence (AI) Disclosure
During the preparation of this manuscript, a large language model (ChatGPT, by OpenAI) was used solely for language editing and stylistic improvements in select paragraphs. No sections involving the generation, analysis, or interpretation of research data were produced by generative AI. All scientific content was created and verified by the authors. Furthermore, no figures or visual data were generated or modified using generative AI or machine learning–based image enhancement tools.
- Received April 9, 2025.
- Revision received April 22, 2025.
- Accepted April 23, 2025.
- Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).









